Hepatocellular carcinoma clinical trials

Access comprehensive clinical trial information for Hepatocellular carcinoma through Pure Global AI's free database. This collection includes 402 clinical trials across multiple phases including N/A, Phase 2, Phase 4. Currently, 134 trials are actively recruiting participants.

Research for Hepatocellular carcinoma is being conducted in Japan, China, South Korea and 7+ other countries. Leading sponsors include West China Hospital, Sichuan University and University of Tsukuba. Pure Global AI offers free access to clinical trial data from ClinicalTrials.gov, WHO ICTRP, and regional registries worldwide.

Pure Global AI provides free access to 402 clinical trials studying Hepatocellular carcinoma, aggregated from major global registries including ClinicalTrials.gov, WHO ICTRP, and regional databases.

The trials span multiple phases, from early Phase 1 safety studies to large-scale Phase 3 efficacy trials, conducted across 10+ countries.

Top research sponsors include West China Hospital, Sichuan University, University of Tsukuba, Niigata Hepatocellular Carcinoma Therapy Study Group, among others.